Roche's Experimental Obesity Drug Delivers Up to 22.5% Weight Loss in Phase-II Trial sheeba farhat28 Jan 2026 4:46 PM ISTRoche's experimental obesity drug CT-388 reduces appetite and is in the same class as Lilly's market-leading Zepbound, also known as tirzepatide and...
No Link to Suicidal Thoughts: USFDA Seeks Label Change for Popular Weight-Loss Drugs Wegovy, Zepbound sheeba farhat14 Jan 2026 6:57 PM ISTThe warnings, part of their original approval, were based on reports of such events observed with a variety of older medicines used or studied for...
Ixekizumab and Tirzepatide combo Improves PsA Control and Weight Loss, suggests study Dr. Kamal Kant Kohli13 Jan 2026 8:15 PM ISTThe TOGETHER-PsA study shows that combining ixekizumab with tirzepatide leads to significantly better psoriatic arthritis disease control and greater...
Medical Bulletin 10/January/2026 Anshika Mishra10 Jan 2026 3:00 PM ISTHere are the top medical news for today:Review suggests most GLP-1 users regain weight within two years after stopping Weight loss drugs work wonders...
Review suggests most GLP-1 users regain weight within two years after stopping Anshika Mishra10 Jan 2026 8:00 AM ISTWeight loss drugs work wonders for shedding pounds, but stopping them can bring the weight back faster than ever. A new University of Oxford review...
Eli Lilly Expands Immunology Pipeline with USD 1.2 Billion Ventyx Buyout sheeba farhat9 Jan 2026 2:53 PM ISTThis is Lilly's first major transaction of 2026, following a year when its market value topped USD 1 trillion on surging sales of GLP-1 drugs...
Eli Lilly, Nimbus Tie Up in USD 1.35 Billion AI-Driven Pact to Develop Oral Obesity Drugs sheeba farhat7 Jan 2026 4:11 PM ISTNimbus will use its AI to help identify drug candidates, while Lilly will contribute its metabolic-disease expertise to develop an easy-to-take oral...
Tirzepatide may only temporarily suppress brain activity involved in "food noise", suggests study Dr. Kamal Kant Kohli24 Nov 2025 9:00 PM ISTA rare glimpse into the brain activity of a patient with obesity and loss of control eating on tirzepatide, marketed as Mounjaro and Zepbound, ...
Eli Lilly joins trillion-dollar club, fueled by weight loss drug demand boom Ruchika Sharma22 Nov 2025 5:49 PM ISTBengaluru: Eli Lilly just hit a USD 1 trillion in market value, becoming the first-ever pharmaceutical company to join the exclusive...
Biocon targets launch for generic Wegovy in India by 2027 Ruchika Sharma17 July 2025 5:20 PM ISTBiopharmaceutical company Biocon is planning to submit a request for approval of generic copies of the blockbuster weight-loss drug Wegovy in India by...
WHO to back use of weight-loss drugs as obesity treatment in adults Ruchika Sharma5 May 2025 11:00 AM ISTLondon: The World Health Organization (WHO) is set to officially back the use of weight-loss drugs as a treatment for obesity in adults for the...
Sun Pharma eyes to launch obesity drug in five years: MD Ruchika Sharma1 March 2025 2:34 PM ISTMumbai: Pharma major, Sun Pharmaceutical, is gearing up to introduce its experimental anti-obesity and type 2 diabetes medicine in the next...
